A recent study has identified a possible hydrocephalus therapeutic target in the proteoglycan TSK, an ependymal-derived signal required for the proper levels of NSPC proliferation and survival in the mouse postnatal V-SVZ (Istiaq and Ohta, 2022). Here, TSKU is linked to Hydrocephalus.